Skip Over Navigation Links

NIH Radio

New Treatment Found to Reduce Vision Loss from Central Retinal Vein Occlusion – 1

Narrator: This is NIH Health Matters. The second-most common cause of vision loss in this country results from a condition known as retinal vein occlusion, which is a blockage in the blood supply from the retina—the light-sensitive tissue in the back of the eye. Dr. Emily Chew at the National Eye Institute says a recent study, called the Standard Care vs. Corticosteroid for Retinal Vein Occlusion, or SCORE study evaluated treatment methods.

Dr. Chew: The SCORE study really consists of two separate studies looking at two different aspects – but a similar disease in the same sort of spectrum – looking at retinal vein occlusions.

Narrator: For details on the SCORE study visit www.nei.nih.gov/score. Health Matters is produced by the National Institutes of Health, part of the US Department of Health and Human Services.

Search Tips

Contact Us

Send questions or comments to:
Joe Balintfy
NIH News Media Branch
NIHRadio@mail.nih.gov
301-435-7557

About NIH Radio

NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.

All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.

NIH Radio is a service of the Office of Communications & Public Liaison.

This page last reviewed on March 25, 2011

Social Media Links